Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.
AUTOR(ES)
Gilbert, B E
RESUMO
Mice lethally infected with Candida albicans were exposed to small-particle aerosols containing amphotericin B-liposomes. The drug, when administered twice daily for 2 h (0.58 mg/kg of body weight per day) on days 1, 2, and 3 postinoculation, significantly reduced the numbers of Candida organisms in the kidneys. Aerosol treatment increased the survival time of mice given 2 2-h treatments once a week for 4 weeks. A twice-weekly, 2-h small-particle aerosol administration of amphotericin B-liposomes for 1, 2, or 3 weeks significantly increased both the mean time of survival and percent survival.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284455Documentos Relacionados
- Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice.
- Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice.
- PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice.
- Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice.
- Successful treatment using gentamicin liposomes of Salmonella dublin infections in mice.
